Subramanian Dharmarajan

Subramanian Dharmarajan

Auto-generated profile, based on publicly available information

Subramanian Dharmarajan

Department of Biology, Indiana University—Purdue University Indianapolis, Indianapolis, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2023 in Diabetologia
Verified
Journal Article
Open access
PDF file
SDSubramanian Dharmarajan
Subramanian Dharmarajan
CCCasandra Carrillo
Casandra Carrillo
ZQZhonghua Qi
Zhonghua Qi
JWJonathan M. Wilson
Jonathan M. Wilson
ABAnthony J. Baucum
Anthony J. Baucum
Teri L Belecky-AdamsTeri L Belecky-Adams
Teri L Belecky-Adams
Aims/hypothesis: The loss of pericytes surrounding the retinal vasculature in early diabetic retinopathy underlies changes to the neurovascular unit that lead to more destructive forms of the disease. However, it is unclear which changes lead to loss of retinal pericytes. This study investigated the hypothesis that chronic increases in one or more inflammatory factors mitigate the signalling pathways needed for pericyte survival. Methods: Loss of pericytes and levels of inflammatory markers at the mRNA and protein levels were investigated in two genetic models of diabetes, Ins2Akita/+ (a model of type 1 diabetes) and Leprdb/db (a model of type 2 diabetes), at early stages of diabetic retinopathy. In addition, changes that accompany gliosis and the retinal vasculature were determined. Finally, changes in retinal pericytes chronically incubated with vehicle or increasing amounts of IFNγ were investigated to determine the effects on pericyte survival. The numbers of pericytes, microglia, astrocytes and endothelial cells in retinal flatmounts were determined by immunofluorescence. Protein and mRNA levels of inflammatory factors were determined using multiplex ELISAs and quantitative reverse transcription PCR (qRT-PCR). The effects of IFNγ on the murine retinal pericyte survival-related platelet-derived growth factor receptor β (PDGFRβ) signalling pathway were investigated by western blot analysis. Finally, the levels of cell death-associated protein kinase C isoform delta (PKCδ) and cleaved caspase 3 (CC3) in pericytes were determined by western blot analysis and immunocytochemistry. Results: The essential findings of this study were that both type 1 and 2 diabetes were accompanied by a similar progression of retinal pericyte loss, as well as gliosis. However, inflammatory factor expression was dissimilar in the two models of diabetes, with peak expression occurring at different ages for each model. Retinal vascular changes were more severe in the type 2 diabetes model. Chronic incubation of murine retinal pericytes with IFNγ decreased PDGFRβ signalling and increased the levels of active PKCδ and CC3. Conclusions/interpretation: We conclude that retinal inflammation is involved in and sustains pericyte loss as diabetic retinopathy progresses. Moreover, IFNγ plays a critical role in reducing pericyte survival in the retina by reducing activation of the PDGFRβ signalling pathway and increasing PKCδ levels and pericyte apoptosis. Graphical

5 April 2017 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
SDSubramanian Dharmarajan
Subramanian Dharmarajan
DFDebra L. Fisk
Debra L. Fisk
CSChristine M. Sorenson
Christine M. Sorenson
NSNader Sheibani
Nader Sheibani
Teri L Belecky-AdamsTeri L Belecky-Adams
Teri L Belecky-Adams
Our previous studies have shown that BMP7 is able to trigger activation of retinal macroglia. However, these studies showed the responsiveness of Müller glial cells and retinal astrocytes in vitro was attenuated in comparison to those in vivo, indicating other retinal cell types may be mediating the response of the macroglial cells to BMP7. In this study, we test the hypothesis that BMP7-mediated gliosis is the result of inflammatory signaling from retinal microglia. Adult mice were injected intravitreally with BMP7 and eyes harvested 1, 3, or 7 days postinjection. Some mice were treated with PLX5622 (PLX) to ablate microglia and were subsequently injected with control or BMP7. Processed tissue was analyzed via immunofluorescence, RT-qPCR, or ELISA. In addition, cultures of retinal microglia were treated with vehicle, lipopolysaccharide, or BMP7 to determine the effects of BMP7-isolated cells. Mice injected with BMP7 showed regulation of various inflammatory markers at the RNA level, as well as changes in microglial morphology. Isolated retinal microglia also showed an upregulation of BMP-signaling components following treatment. In vitro treatment of retinal astrocytes with conditioned media from activated microglia upregulated RNA levels of gliosis markers. In the absence of microglia, the mouse retina showed a subdued gliosis and inflammatory response when exposed to BMP7. Gliosis resulting from BMP7 is mediated through an inflammatory response from retinal microglia.

9 July 2014 in BMC Developmental Biology
Verified
Journal Article
Open access
PDF file
STSarika Tiwari
Sarika Tiwari
SDSubramanian Dharmarajan
Subramanian Dharmarajan
MSMahesh Shivanna
Mahesh Shivanna
DODeborah C Otteson
Deborah C Otteson
Teri L Belecky-AdamsTeri L Belecky-Adams
Teri L Belecky-Adams
Histone deacetylases (HDACs) play important roles in glial cell development and in disease states within multiple regions of the central nervous system. However, little is known about HDAC expression or function within the optic nerve. As a first step in understanding the role of HDACs in optic nerve, this study examines the spatio-temporal expression patterns of methylated histone 3 (K9), acetylated histone 3 (K18), and HDACs 1–6 and 8–11 in the developing murine optic nerve head.

31 July 2014
Verified
Journal Article
Open access
SDSubramanian Dharmarajan
Subramanian Dharmarajan
ZGZafer Gurel
Zafer Gurel
SWShoujian Wang
Shoujian Wang
CSChristine M. Sorenson
Christine M. Sorenson
NSNader Sheibani
Nader Sheibani
Teri L Belecky-AdamsTeri L Belecky-Adams
Teri L Belecky-Adams
The focus of this study was to determine whether bone morphogenetic proteins (BMPs) trigger reactive gliosis in retinal astrocytes and/or Müller glial cells. Retinal astrocytes and the Müller glial cell line MIO-M1 were treated with vehicle, BMP7, or BMP4. Samples from the treated cells were analyzed for changes in gliosis markers using reverse transcriptase – quantitative PCR (RT-qPCR) and western blotting. To determine potential similarities and differences in gliosis states, control and BMP-treated cells were compared to cells treated with sodium peroxynitrite (a strong oxidizing agent that will bring about some aspects of gliosis). Last, mature mice were microinjected intravitreally with BMP7 and analyzed for changes in gliosis markers using RT-qPCR, western blotting, and immunohistochemistry. Treatment of retinal astrocyte cells and Müller glial cells with BMP7 regulated various reactive gliosis markers. When compared to the response of cells treated with sodium peroxynitrite, the profiles of gliosis markers regulated due to exposure to BMP7 were similar. However, as expected, the profiles including the oxidative agent and growth factor were not identical. Treatment of cells with BMP4, however, showed an attenuated response in comparison to peroxynitrite and BMP7 treatment. Injection of BMP7 into the mouse retina also triggered a reactive gliosis response 7 days after injection. BMP7 induced changes in levels of mRNA and protein markers typically associated with reactive gliosis in retinal astrocytes and Müller glial cells, including glial fibrillary acidic protein (GFAP), glutamine synthetase (GS), a subset of chondroitin sulfate proteoglycans (CSPGs), matrix metalloproteinases (MMPs), and other molecules.

1 December 2018 in Gene Expression Patterns
Verified
Journal Article
Open access
ASAnkita Saha
Ankita Saha
STSarika Tiwari
Sarika Tiwari
SDSubramanian Dharmarajan
Subramanian Dharmarajan
DODeborah C. Otteson
Deborah C. Otteson
Teri L Belecky-AdamsTeri L Belecky-Adams
Teri L Belecky-Adams
Background: The acetylation state of histones has been used as an indicator of the developmental state of progenitor and differentiating cells. The goal of this study was to determine the nuclear localization patterns of Class I histone deacetylases (HDACs) in retinal progenitor cells (RPCs) and retinal ganglion cells (RGCs), as the first step in understanding their potential importance in cell fate determination within the murine retina. Results: The only HDAC to label RPC nuclei at E16 and P5 was HDAC1. In contrast, there was generally increased nuclear localization of all Class I HDACs in differentiating RGCs. Between P5 and P30, SOX2 expression becomes restricted to Muller glial, cholinergic amacrine cells, and retinal astrocytes. Cholinergic amacrine showed a combination of changes in nuclear localization of Class I HDACs. Strikingly, although Muller glia and retinal astrocytes express many of the same genes, P30 Muller glial cells showed nuclear localization only of HDAC1, while retinal astrocytes were positive for HDACs 1, 2, and 3. Conclusion: These results indicate there may be a role for one or more of the Class I HDACs in retinal cell type-specific differentiation.

24 April 2013
Verified
Book Chapter
Open access
PDF file
TLTeri L.
Teri L.
ECEllen C.
Ellen C.
JMJonathan M.
Jonathan M.
SDSubramanian Dharmaraj
Subramanian Dharmaraj